Debbie Ormsby

Debbie Ormsby, MBA (Exec), MRPharmS, GAICD, serves as the Vice President of Global Investor Relations and Corporate Development and Vice President of Global Medical Affairs at Anteris Technologies since June 2022. Previously, Debbie held the position of Director of Commercialisation at The Heart Research Institute from November 2020 to May 2022 and served as a Non-Executive Director at Haemokinesis in 2021-2022. With extensive experience as an Independent Consultant from June 2017 to October 2020, Debbie has also been a Managing Director (Country Head) for Australia and New Zealand at Meda and The Medicines Company. Earlier roles include Therapeutic Group Manager at Roche Pharmaceuticals and various positions at Actelion and Roche, providing a strong foundation in biopharmaceuticals and life sciences. Debbie's educational background includes a Master of Business Administration (Executive) from AGSM @ UNSW Business School and a BPharm (Hons) from the University of Nottingham, along with completion of the Company Directors Course at the Australian Institute of Company Directors.